VSRV Stock News 0.0840 05/07/2014 21:37:54 Voiceserve Inc. (

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Voiceserve Inc. (VSRV) 0.0840 $VSRV

Voiceserve Scheduled to Launch Its WebRTC Based RCS Portal at the GSMA
Marketwire - Thu Feb 20, 8:31AM CST
Voiceserve Inc (VSRV) (OTCBB: VSRV) (OTCQB: VSRV) and its Subsidiary Voipswitch a complete VOIP solutions provider, today announced that it will be exhibiting innovative RCS products from its industry-leading portfolio at Mobile World Congress (MWC), to be held February 24-27 in Barcelona, Spain.

Ecrio announces "Nimbus" - cloud based solution for VoLTE & RCS
PR Newswire - Thu Feb 20, 12:00AM CST
Ecrio announced today that it will be demonstrating at the Mobile World Congress in Barcelona its innovative cloud based solution that connects tablets and M2M endpoints requiring voice and video services over LTE networks being deployed globally.

TCA Capital Signs a $5 Million Credit Line for Voiceserve (VSRV)
Marketwire - Wed Sep 04, 8:31AM CDT
TCA Global Credit Master Fund, "TCA", has committed to lend a total of 5MM USD to Voiceserve, Inc. (OTCBB: VSRV) through one of the funds senior secured loan facilities, with the initial draw set at $1Million.

Voiceserve Wins $1 Million Mobile Soft Phone Dialler Contract from a Tier 1 Carrier
Marketwire - Thu Jul 11, 9:06AM CDT
Voiceserve, Inc. (OTCBB: VSRV)(OTCQB: VSRV), a next-generation Internet telephony software and service provider, today announced that it has won a network services and a mobile dialler contract from a major Tier 1 carrier. This is a five year contract that is valued over $1 million and adds to Voiceserve's repertoire of significant contract wins within the last few months.

Voiceserve Announces Third Quarter Results
PR Newswire Europe - Wed Feb 20, 8:05AM CST
NEW YORK and LONDON, February 20, 2013 /PRNewswire/ --
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors of Sage Therapeutics Have Chance to Join Lawsuit

Updated Category News Views 88

Introduction to the Class Action Lawsuit Attention, investors! There's an important opportunity arising for shareholder litigation against Sage Therapeutics, Inc. The legal firm Bronstein, Gewirtz & Grossman, LLC is officially notifying individuals who have invested in Sage Therapeutics about a class action lawsuit that has now been filed. If you have faced substantial...

Continue Reading
FARO Technologies Revolutionizes 3D Metrology with Leap ST

Updated Category News Views 105

FARO Technologies Enhances 3D Metrology with Leap ST FARO Technologies, Inc. (NASDAQ: FARO) is pushing the boundaries of handheld scanning technology with the introduction of the Leap ST. This launch marks a significant expansion of FARO's product portfolio, positioning the company among the few firms offering a comprehensive range of portable 3D metrology solutions. Leap...

Continue Reading
Strong Financial Performance and Growth Strategies at TORM PLC

Updated Category News Views 181

TORM PLC Reports Robust Q3 2025 Financial Results TORM PLC has demonstrated remarkable resilience and adaptability, reporting its strongest quarterly results in 2025. This achievement underscores the effectiveness of TORM's integrated operating model, as highlighted by the CEO. The company continues to prioritize creating long-term value for its shareholders while...

Continue Reading
Manhattan Associates Faces Legal Challenges Amid Shareholder Losses

Updated Category News Views 304

Manhattan Associates Faces Legal Challenges Following Shareholder Loss In recent developments, Manhattan Associates, Inc. (NASDAQ: MANH) is under scrutiny as a class action lawsuit has been filed against the company. This action comes after an alarming drop in shareholder value, amounting to over $4 billion. The lawsuit is pivotal as it involves allegations of misleading...

Continue Reading
BioLife Solutions Announces Upcoming Financial Results

Updated Category News Views 91

BioLife Solutions to Share Key Financial Insights BioLife Solutions, Inc. (NASDAQ: BLFS), a pioneering developer and supplier of bioproduction products and services specializing in cell and gene therapies, is gearing up for a significant event. The company plans to release its financial results for the third quarter of 2024 after market hours on November 12, 2024. This is...

Continue Reading